Solid Biosciences Statistics

Total Valuation

SLDB has a market cap or net worth of $206.17 million. The enterprise value is $51.78 million.

Market Cap	206.17M
Enterprise Value	51.78M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

SLDB has 39.95 million shares outstanding. The number of shares has increased by 98.88% in one year.

Current Share Class	39.95M
Shares Outstanding	39.95M
Shares Change (YoY)	+98.88%
Shares Change (QoQ)	+1.24%
Owned by Insiders (%)	0.84%
Owned by Institutions (%)	37.86%
Float	18.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.16
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.15.

Current Ratio	7.85
Quick Ratio	7.49
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -65.79% and return on invested capital (ROIC) is -38.61%.

Return on Equity (ROE)	-65.79%
Return on Assets (ROA)	-35.33%
Return on Capital (ROIC)	-38.61%
Revenue Per Employee	n/a
Profits Per Employee	-$1.16M
Employee Count	88
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +93.00% in the last 52 weeks. The beta is 1.93, so SLDB's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	+93.00%
50-Day Moving Average	6.37
200-Day Moving Average	8.46
Relative Strength Index (RSI)	36.08
Average Volume (20 Days)	308,396

Short Selling Information

The latest short interest is 1.48 million, so 3.71% of the outstanding shares have been sold short.

Short Interest	1.48M
Short Previous Month	1.77M
Short % of Shares Out	3.71%
Short % of Float	7.89%
Short Ratio (days to cover)	4.44

Income Statement

Revenue	n/a
Gross Profit	-76.56M
Operating Income	-112.10M
Pretax Income	-90.25M
Net Income	-102.44M
EBITDA	-109.92M
EBIT	-112.10M
Earnings Per Share (EPS)	-$2.91

Full Income Statement

Balance Sheet

The company has $171.12 million in cash and $24.72 million in debt, giving a net cash position of $146.40 million or $3.66 per share.

Cash & Cash Equivalents	171.12M
Total Debt	24.72M
Net Cash	146.40M
Net Cash Per Share	$3.66
Equity (Book Value)	167.02M
Book Value Per Share	4.29
Working Capital	156.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$91.19 million and capital expenditures -$540,000, giving a free cash flow of -$91.73 million.

Operating Cash Flow	-91.19M
Capital Expenditures	-540,000
Free Cash Flow	-91.73M
FCF Per Share	-$2.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLDB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-98.88%
Shareholder Yield	-98.88%
Earnings Yield	-49.98%
FCF Yield	-44.75%

Analyst Forecast

The average price target for SLDB is $17.50, which is 239.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.50
Price Target Difference	239.15%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-27.02%

Stock Forecasts

Stock Splits

The last stock split was on October 28, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Oct 28, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1